Enter the first few characters of Company and click 'Go'
Quarterly Results of AstraZeneca Pharma India Ltd. Company(Figures in Rs crores)
|
|
Dec 31, 2023 |
Sep 30, 2023 |
Jun 30, 2023 |
Mar 31, 2023 |
Dec 31, 2022 |
Net Sales / Income |
305.79 |
311.07 |
295.47 |
284.70 |
249.81 |
Other Income |
9.66 |
8.37 |
8.10 |
8 |
7.20 |
Net Profit/Loss |
15.80 |
52.37 |
53.86 |
17.27 |
29.30 |
Raw Material |
37.52 |
38.80 |
19.08 |
21.62 |
27.10 |
Power And Fuel |
0 |
0 |
0 |
0 |
0 |
Employee Expenses |
63.23 |
65.27 |
54.97 |
66.86 |
62.68 |
Excise |
|
|
|
|
|
Admin And Selling Expenses |
0 |
0 |
0 |
0 |
0 |
Research And Devlopment Expenses |
0 |
0 |
0 |
0 |
0 |
Expenses Capitalised |
0 |
0 |
0 |
0 |
0 |
Other Expenses |
260.74 |
210.86 |
165.51 |
163.08 |
133.31 |
Provisions Made |
0 |
0 |
0 |
0 |
0 |
Interest |
0.61 |
0.50 |
0.15 |
0.09 |
0.20 |
Gross Profit |
24.10 |
60.63 |
75.20 |
67.76 |
43.59 |
Depreciation |
3.70 |
3.67 |
3.80 |
4.25 |
4.13 |
Taxation |
4.60 |
21.01 |
17.54 |
6.01 |
10.15 |
Extra Ordinary Item |
0 |
16.43 |
0 |
-40.23 |
0 |
Prior Year Adjustments |
0 |
0 |
0 |
0 |
0 |
Equity Capital |
5 |
5 |
5 |
5 |
5 |
Equity Dividend Rate |
0 |
0 |
0 |
0 |
0 |
Agg.Of Non-Prom. Shares (in lacs) |
0 |
0 |
0 |
0 |
0 |
Agg.Of Non PromotoHolding (%) |
0 |
0 |
0 |
0 |
0 |
EPS (in Rs.) |
6.32 |
20.95 |
21.54 |
6.91 |
11.72 |
|
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article